These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24258999)

  • 21. FDG PET in early stage cutaneous malignant melanoma.
    McIvor J; Siew T; Campbell A; McCarthy M
    J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study.
    Prakoso E; Fulham M; Thompson JF; Selby WS
    Gastrointest Endosc; 2011 Apr; 73(4):750-6. PubMed ID: 21288518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
    Clark PB; Soo V; Kraas J; Shen P; Levine EA
    Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma.
    Bastiaannet E; Hoekstra HJ; Hoekstra OS
    Methods Mol Biol; 2011; 727():123-39. PubMed ID: 21331932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/CT variants and pitfalls in malignant melanoma.
    Aide N; Iravani A; Prigent K; Kottler D; Alipour R; Hicks RJ
    Cancer Imaging; 2022 Jan; 22(1):3. PubMed ID: 34983677
    [No Abstract]   [Full Text] [Related]  

  • 27. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
    Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
    Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S-100B and FDG-PET/CT in therapy response assessment of melanoma patients.
    Strobel K; Skalsky J; Steinert HC; Dummer R; Hany TF; Bhure U; Seifert B; Pérez Lago M; Joller-Jemelka H; Kalff V
    Dermatology; 2007; 215(3):192-201. PubMed ID: 17823514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
    Constantinidou A; Hofman M; O'Doherty M; Acland KM; Healy C; Harries M
    Melanoma Res; 2008 Feb; 18(1):56-60. PubMed ID: 18227709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
    Chin K; Finger PT; Kurli M; Tena LB; Reddy S
    Optometry; 2007 Aug; 78(8):396-401. PubMed ID: 17662928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
    Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
    Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients.
    Bastiaannet E; Oyen WJ; Meijer S; Hoekstra OS; Wobbes T; Jager PL; Hoekstra HJ
    Br J Surg; 2006 Feb; 93(2):243-9. PubMed ID: 16323165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography/ computed tomography for N-and M-staging of malignant melanoma].
    Gu H; Xu W; Song X; Dai D; Zhu L; Wang J
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(17):1309-12. PubMed ID: 25142850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical applications of positron emission tomography-computed tomography in oncology.
    Kumar R; Halanaik D; Malhotra A
    Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Steinert HC; Huch Böni RA; Buck A; Böni R; Berthold T; Marincek B; Burg G; von Schulthess GK
    Radiology; 1995 Jun; 195(3):705-9. PubMed ID: 7753998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.
    Kurli M; Chin K; Finger PT
    Br J Ophthalmol; 2008 Apr; 92(4):479-82. PubMed ID: 18369064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.